The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma (Q43829880)
Jump to navigation
Jump to search
scientific article published in February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma |
scientific article published in February 2013 |
Statements
1 reference
The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma (English)
1 reference
1 reference
S E Kent
1 reference
Z Diamant
1 reference
D Singh
1 reference
B J O'Connor
1 reference
P S Saggu
1 reference
V Norris
1 reference
1 February 2013
1 reference
1 reference
43
1 reference
2
1 reference
177-186
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference